How Do GLP-1s Work for Weight Loss?

Posted on October 7, 2024 by Sally-Anne Turner

Weight loss has never been an easy feat, particularly when factors outside of your control are impacting your ability to lose weight effectively or sustainably with diet and exercise alone. Genetics, metabolism, and hormonal imbalances can all have negative effects on weight and make it incredibly hard to get the weight off without sufficient support.

For many people struggling with obesity, the traditional advice to "eat less and move more" simply doesn't address the underlying biological factors that make weight management so challenging. Your body has complex systems designed to maintain your current weight, and these systems can work against your weight loss efforts even when you're doing everything "right". This is particularly frustrating for individuals who have tried multiple diets, joined gyms, worked with personal trainers, and made genuine efforts to change their lifestyle, only to see minimal results or watch the weight return shortly after losing it.

The reality is that obesity is not simply a matter of willpower or personal choice. It's a complex medical condition influenced by numerous factors, including genetic predisposition, hormonal regulation, metabolic rate, gut microbiome composition, sleep quality, stress levels, certain medications, and underlying health conditions. For decades, healthcare professionals and researchers have understood that many people need medical intervention to successfully manage their weight, but effective pharmaceutical options were limited and often came with significant side effects or modest results.

This is why pharmaceutical companies were overjoyed when they found that a medication mechanism, originally prescribed to treat type 2 diabetes, had incredible weight loss results for those living with obesity. The discovery that GLP-1 receptor agonists could produce substantial, sustained weight loss represented a genuine breakthrough in obesity medicine. Clinical trials demonstrated that patients using these medications could lose an average of 15-20% of their body weight when combined with lifestyle modifications – results that far exceeded what was typically achievable with older weight loss medications or diet and exercise alone.

Now that medical governance bodies have approved some of these medications for the treatment of obesity, the world of weight health management has totally transformed. But what are GLP-1s, and how do they work for weight loss? Understanding the science behind these medications can help you make informed decisions about whether they might be appropriate for your weight loss journey and what results you can realistically expect when using them as part of a comprehensive treatment programme.

What are GLP-1s?

GLP-1, or glucagon-like peptide-1, is a hormone naturally produced in the stomach when we have eaten a meal. This hormone plays a crucial role in regulating appetite, glucose metabolism, and energy balance in the body. It's part of a family of hormones called incretins, which are released by cells in your intestinal lining in response to food intake, particularly when you consume carbohydrates and fats.

The discovery of GLP-1 and its functions represents decades of research into how the human body regulates hunger, satiety, and blood sugar levels. Scientists first identified this hormone in the 1980s, but it took many more years to understand its full potential for treating both diabetes and obesity. What makes GLP-1 particularly interesting is that it acts on multiple systems in your body simultaneously, creating a coordinated response that helps regulate both appetite and metabolism.

It stimulates insulin secretion to regulate blood sugar, suppresses glucagon to reduce hunger levels, and delays the emptying of the stomach to increase feelings of being satisfied and full after a meal. When you eat, GLP-1 is released from L-cells in your small intestine and travels through your bloodstream to various organs, including your pancreas, brain, and stomach. In your pancreas, it signals beta cells to release insulin when blood glucose levels are elevated, helping to keep your blood sugar within a healthy range. This glucose-dependent action is important because it means GLP-1 only stimulates insulin release when needed, reducing the risk of dangerously low blood sugar levels.

In your brain, GLP-1 acts on receptors in the hypothalamus and other areas involved in appetite regulation. This is where the weight loss magic happens – GLP-1 essentially tells your brain that you've had enough to eat, reducing hunger signals and increasing feelings of satiety. Many people who struggle with weight management report that they never feel truly full or satisfied after meals, constantly thinking about food and experiencing strong cravings. GLP-1 helps to normalise these signals, making it much easier to eat appropriate portion sizes without feeling deprived or constantly hungry.

In your stomach, GLP-1 slows gastric emptying, which means food stays in your stomach for longer. This prolonged presence of food creates a sustained feeling of fullness and helps prevent the rapid blood sugar spikes and crashes that can trigger hunger and cravings shortly after eating. This mechanism is particularly beneficial for people who tend to eat large portions or who experience hunger returning quickly after meals.

However, there's a challenge with natural GLP-1: it breaks down very quickly in your body, typically within just a few minutes. An enzyme called DPP-4 rapidly degrades natural GLP-1, which means its beneficial effects are short-lived. This is where pharmaceutical GLP-1 receptor agonists come in – these medications are designed to resist breakdown by DPP-4, allowing them to remain active in your body for much longer periods, from several hours to several days depending on the specific medication.

How do GLP-1s injections work?

GLP-1s injections have active ingredients that work by activating GLP-1 receptors in the body, called GLP-1 receptor agonists. This mimics the effect of the naturally occurring hormone and leads to several beneficial effects for weight loss. Firstly, they help suppress the appetite, making it easier to follow a reduced-calorie diet. This can result in decreased food intake and a calorie deficit, which is essential for weight loss.

The mechanism by which GLP-1 receptor agonists suppress appetite is multifaceted and sophisticated. When you inject these medications, they bind to GLP-1 receptors throughout your body, but particularly in key areas of your brain that control hunger and satiety. The hypothalamus, which acts as your body's appetite control centre, receives signals from GLP-1 that reduce the drive to eat and increase feelings of satisfaction with smaller portions. Many patients report that for the first time in years, they can eat a normal-sized meal and feel genuinely full, rather than constantly thinking about their next snack or feeling the need to finish everything on their plate.

What's particularly remarkable about GLP-1 medications is that they don't just reduce physical hunger – they also significantly decrease what many people describe as "food noise" or "food chatter". This is the constant mental preoccupation with food, the intrusive thoughts about eating, and the compulsive urge to snack that many people with obesity experience. Patients frequently report that after starting GLP-1 therapy, they simply stop thinking about food as much. They don't find themselves planning their next meal while eating their current one, they don't experience the same intense cravings for specific foods, and they can walk past their favourite treats without feeling an overwhelming urge to indulge.

Stimulating GLP-1s also regulates blood sugar levels and promotes insulin secretion, helping to control cravings for sugary and high-calorie foods. When your blood sugar levels fluctuate dramatically throughout the day – spiking after meals and crashing a few hours later – these fluctuations can trigger intense hunger and cravings, particularly for quick-energy foods like sweets, biscuits, and refined carbohydrates. By helping to maintain more stable blood sugar levels, GLP-1 medications reduce these crisis-driven eating episodes that can derail even the most determined weight loss efforts.

They slow down the emptying of the stomach, leading to increased feelings of fullness and satiety. This delayed gastric emptying is one of the most noticeable effects for many patients. Food remains in your stomach for longer, creating a sustained feeling of fullness that can last for hours after eating. This means you naturally eat less frequently, feel satisfied with smaller portions, and don't experience the rapid return of hunger that often occurs when the stomach empties quickly. Some patients do experience temporary side effects related to this slower digestion, such as feeling uncomfortably full if they eat too much, but these effects typically improve as the body adjusts to the medication and as patients learn to eat appropriate portion sizes.

Finally, GLP-1s increase metabolism, leading to higher energy expenditure, even at rest. This combination of effects helps individuals achieve weight loss by creating a favourable environment for calorie reduction and increased energy expenditure. Research suggests that GLP-1 receptor agonists may influence energy expenditure through several mechanisms, including effects on brown adipose tissue (which burns calories to generate heat) and improvements in insulin sensitivity that allow your body to use energy more efficiently.

The metabolic benefits extend beyond just burning more calories. GLP-1 medications appear to preferentially reduce visceral fat – the dangerous fat that accumulates around your organs and is strongly associated with metabolic disease, cardiovascular problems, and type 2 diabetes. Many patients notice that even as they lose weight, their body composition improves significantly, with reductions in waist circumference that exceed what would be expected from weight loss alone. This suggests that GLP-1 therapy is helping to target the most harmful type of body fat.

It's important to understand that GLP-1 injections are not stimulants and they don't work by artificially speeding up your metabolism or suppressing appetite through central nervous system stimulation like older weight loss medications. Instead, they work with your body's natural regulatory systems, essentially helping to restore normal appetite and satiety signalling that has become dysregulated in obesity. This makes them generally safer and better tolerated than many previous weight loss medications, though they can still cause side effects that need to be managed with proper medical supervision.

Contact Bodyline today to find out more about our safe and effective weight loss programmes and range of treatment options.

What GLP-1s are available for weight loss?

Several GLP-1s medications have been approved for weight loss treatment in the UK. These include:

1. Liraglutide (Saxenda): Liraglutide is a prescription injectable medication that has been approved for obesity treatment and weight management in individuals with obesity (or overweight who have at least one weight-related health condition). It is self-administered once daily. Saxenda was one of the first GLP-1 receptor agonists to be approved specifically for weight management, and it has an established track record of safety and efficacy. The daily injection schedule means that the medication level in your body remains relatively constant, which some patients find helps with consistent appetite control throughout the day. Clinical trials showed that patients using Saxenda lost an average of 5-10% of their body weight over 56 weeks when combined with lifestyle modifications. At Bodyline Clinic, we have extensive experience prescribing Saxenda as part of our comprehensive weight loss programmes, and many patients have achieved excellent results with this medication.
2. Semaglutide (Wegovy): Similarly, semaglutide is a prescription injectable medication that is most well known in the medical weight loss industry. It has been approved in the UK for chronic weight management in individuals with obesity or overweight who have at least one weight-related health condition. It is self-administered once weekly and has been described as "game-changing" for obesity management. Wegovy represents a significant advancement in GLP-1 therapy for weight loss, with clinical trials demonstrating average weight loss of approximately 15% of body weight over 68 weeks. The once-weekly dosing schedule is more convenient for many patients compared to daily injections, and the longer duration of action may provide more consistent appetite suppression throughout the week. Many patients report that Wegovy produces more substantial weight loss than earlier GLP-1 medications, though individual responses vary. The medication has gained considerable attention in both medical circles and popular media due to its impressive efficacy in clinical trials and real-world use.

There is also a combined GLP-1 / GIP dual hormone medication that represents the latest advancement in obesity pharmacotherapy:

1. Tirzepatide (Mounjaro): Tirzepatide is a brand new dual agonist which is a combined GLP-1 and GIP injectable therapy that has just been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) for the treatment of obesity. This groundbreaking new medication has been dubbed the "King Kong" of weight loss treatments as its results have surpassed the other single agonist GLP-1 therapies available. Mounjaro works by activating both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors, creating a synergistic effect that appears to produce even greater weight loss than GLP-1 agonists alone. In clinical trials, patients using the highest dose of tirzepatide lost an average of approximately 20% of their body weight over 72 weeks – results that approach those seen with bariatric surgery. GIP is another incretin hormone that works alongside GLP-1 to regulate blood sugar and appetite, and the combination of both appears to be more effective than either alone. Bodyline Clinic is proud to offer Mounjaro as part of our advanced weight loss injection programmes, giving our patients access to the most effective medical treatments available for obesity management.

It's worth noting that there's also an oral form of semaglutide available called Rybelsus or the Wegovy pill, which was initially approved for type 2 diabetes treatment. While this tablet form offers the convenience of not requiring injections, it's currently less commonly prescribed for weight loss specifically, as the injectable forms have been more extensively studied for obesity treatment and appear to produce better weight loss results. However, for patients who have a strong aversion to injections or who have medical reasons that make injections problematic, oral semaglutide may be an option worth discussing with a healthcare provider.

Each of these medications has slightly different characteristics in terms of dosing schedule, side effect profile, and efficacy. The choice of which GLP-1 or GLP-1/GIP medication is most appropriate for you depends on various factors including your medical history, weight loss goals, lifestyle considerations, budget, and how you respond to the medication. At Bodyline Clinic, our experienced healthcare professionals will conduct a thorough assessment to determine which medication is most suitable for your individual circumstances and will provide ongoing monitoring and support throughout your treatment.

Who can use GLP-1s for weight loss?

According to the MHRA and the National Institute for Health and Care Excellence (NICE), GLP-1s are typically prescribed to individuals who have a body mass index (BMI) that qualifies them as obese (over 30) or overweight (over 27) with weight-related health problems like high blood pressure or prediabetes. These eligibility criteria are based on extensive research demonstrating that the benefits of GLP-1 therapy outweigh the risks for people in these categories, and that these individuals are most likely to experience significant health improvements from weight loss.

The BMI thresholds are slightly different for people from certain ethnic backgrounds, who may be at higher risk of weight-related health problems at lower BMI levels. For example, for people of South Asian, Chinese, other Asian, Middle Eastern, Black African, or African-Caribbean family background, the overweight category begins at a BMI of 23 or above, and obesity at 27.5 or above. This reflects research showing that people from these ethnic groups tend to develop type 2 diabetes and cardiovascular disease at lower BMI levels than white European populations.

Weight-related health conditions that may make you eligible for GLP-1 therapy even if your BMI is between 27 and 30 include type 2 diabetes, prediabetes or impaired glucose tolerance, high blood pressure (hypertension), high cholesterol or dyslipidaemia, obstructive sleep apnoea, non-alcoholic fatty liver disease, polycystic ovary syndrome (PCOS), and cardiovascular disease. If you have any of these conditions, losing weight with the help of GLP-1 medications can significantly improve your health outcomes and may even allow you to reduce or discontinue some of your other medications.

Eligibility for GLP-1s should only be determined by a qualified healthcare professional who will consider factors such as medical history, current medications, and overall health. During your initial consultation at Bodyline Clinic, our experienced nurses and doctors will conduct a comprehensive assessment that includes reviewing your weight history, previous weight loss attempts, current medications, any existing health conditions, family history of obesity and related conditions, and your personal weight loss goals and motivations. This thorough evaluation ensures that GLP-1 therapy is safe and appropriate for you, and allows us to identify any potential contraindications or factors that might affect your treatment plan.

There are certain situations where GLP-1 medications may not be suitable. These include if you have a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2, if you're pregnant, planning to become pregnant, or breastfeeding, if you have severe gastrointestinal disease, if you have a history of pancreatitis, or if you have severe kidney disease. Additionally, GLP-1 medications should be used with caution in people with certain other medical conditions, and your healthcare provider will need to carefully evaluate the risks and benefits in these situations.

Any providers promising GLP-1s like semaglutide to anyone that is interested are not regulated and could be selling black market injectable pens that do not include the correct ingredients or dosage, which can result in severe illness. This is why it is vital to do your research before considering the purchase or use of GLP-1 injections. The rise in popularity of these medications has unfortunately led to a proliferation of unregulated online sellers and even counterfeit products. Some people have experienced serious adverse effects from using medications purchased from unverified sources, including contaminated products, incorrect dosages, or products that don't contain the stated active ingredient at all.

Legitimate providers will always require a proper medical consultation before prescribing GLP-1 medications, will be registered with appropriate regulatory bodies such as the Care Quality Commission (CQC), will provide ongoing medical supervision throughout your treatment, and will source medications from licensed pharmaceutical suppliers. At Bodyline Clinic, we are proud to be CQC-registered and to maintain the highest standards of patient safety and care. We never prescribe weight loss medications without a thorough medical assessment, and we provide comprehensive support throughout your treatment to ensure the best possible outcomes.

Additionally, those that use GLP-1s for weight loss that are not in the BMI range for eligibility can cause health problems down the road. When people who are already at a healthy weight use these medications to lose additional weight, they risk losing too much lean muscle mass, developing nutritional deficiencies, and creating an unhealthy relationship with food and body image. The medications are powerful tools for treating obesity, but they're not appropriate for cosmetic weight loss in people who are already at a healthy weight.

Dr Morgan Toerien is Bodyline's weight, health, and wellness clinical director and explains the importance of appropriate prescribing:

"With these medications one must be very careful, and only use them as they are intended. Everybody has a natural set point for their weight, but if people are using these medications while their set point is in the normal range, then they are creating an environment where there's too much of those hormones. That breakdown is beyond what is physiologically healthy. You also probably find that people will take them to lose the weight and then stop taking them and the weight will go back on. They'll end up with that up and down yo-yo effect, which is far less healthy than the long-term sustainable kind of weight loss. This is especially the case when users are not incorporating diet and exercise, and not modifying their lifestyle. But if you haven't really got the amount of weight to lose, you can do a lot of harm to your body by losing too much."

This expert insight underscores why proper medical supervision is so essential when using GLP-1 medications. These are powerful pharmaceutical interventions that should be used to treat a medical condition – obesity – not as a cosmetic quick-fix for people who simply want to lose a few pounds. When used appropriately in people who genuinely need them, GLP-1 medications can be life-changing and dramatically improve health outcomes. When misused by people who don't meet the eligibility criteria, they can cause harm and perpetuate unhealthy attitudes towards weight and body image.

Where can I buy GLP-1s?

GLP-1s medications like liraglutide, semaglutide, and not forgetting the GLP-1 / GIP tirzepatide, are prescription medications and can only be obtained from healthcare providers like doctors and nurses. It is important to consult with a qualified healthcare professional who can assess your eligibility and prescribe the appropriate GLP-1 / GLP-1-GIP medication for your weight loss journey.

In the UK, there are several legitimate routes to accessing GLP-1 medications for weight loss. The first is through the NHS, though availability on the NHS is currently limited and subject to strict eligibility criteria and local commissioning decisions. Many areas have waiting lists for NHS weight management services, and not all GLP-1 medications are available in all areas. If you meet the eligibility criteria and your local NHS services offer these medications, your GP can refer you to a specialist weight management service for assessment.

The second route is through private healthcare providers like Bodyline Clinic. Private treatment offers several advantages including faster access to treatment without long waiting lists, a wider choice of medications including the newest options like Mounjaro, more frequent monitoring and support appointments, and comprehensive weight loss programmes that combine medication with nutritional guidance, lifestyle coaching, and ongoing clinical support. While private treatment does involve costs, many patients find that the investment is worthwhile given the significant health benefits and quality of life improvements that successful weight loss brings.

It is illegal for sellers to provide prescription medication for sale without prescribing, so if you are not sure you are being prescribed by a regulated healthcare professional, it is much safer to find a different provider. Warning signs of unregulated or potentially dangerous providers include offering to sell medications without requiring a medical consultation, not asking about your medical history or current medications, promising unrealistic results or claiming the medications work without lifestyle changes, offering prices that seem too good to be true, not being registered with the CQC or other appropriate regulatory bodies, and being unable to provide verifiable credentials for their prescribers.

Here at Bodyline, if you are eligible for GLP-1 / GLP-1 – GIP's medications, we can prescribe them within a fully supported medical weight loss programme guaranteed to see you lose weight and make excellent progress towards your weight loss goals. Our programme includes an initial comprehensive medical assessment to determine your eligibility and identify the most appropriate medication for your needs, regular monitoring appointments to track your progress, adjust dosages, and manage any side effects, personalised nutritional guidance to help you make sustainable dietary changes, lifestyle coaching to support behaviour change and habit formation, access to our online support resources and community, and ongoing clinical supervision throughout your treatment.

We have clinics located throughout the Northwest of England, including in Birkenhead, Liverpool, Manchester, Warrington, St Helens, Stockport, and Stoke-on-Trent, making it convenient for patients across the region to access our services. We also offer online consultations for patients who prefer remote appointments or who live outside our clinic catchment areas, making our expertise accessible to people throughout the UK.

To find out more about prices and payment plans, contact us today by completing an online enquiry form or call us on 0800 995 6036. Our friendly team will be happy to answer your questions, explain our treatment programmes in detail, and help you take the first step towards achieving your weight loss goals with safe, effective, medically supervised GLP-1 therapy.

What are the side effects?

Like any medication, GLP-1s and GLP-1s /GIP injections may have potential side effects. Common side effects include nausea, vomiting, diarrhoea, and decreased appetite. These gastrointestinal side effects are generally mild and subside over time as the body adjusts to the medication.

Understanding what to expect in terms of side effects can help you prepare for treatment and manage any symptoms that arise. The most commonly reported side effects are related to the digestive system, which makes sense given that GLP-1 medications slow gastric emptying and affect gut function. Nausea is the most frequent side effect, affecting a significant proportion of patients, particularly when first starting the medication or when increasing the dose. For most people, this nausea is mild to moderate and tends to improve after the first few weeks of treatment as the body adjusts.

Strategies to minimise nausea include eating smaller, more frequent meals rather than large portions, avoiding foods that are very fatty, greasy, or spicy, eating slowly and chewing thoroughly, staying upright for at least an hour after eating, avoiding lying down immediately after meals, staying well-hydrated throughout the day, and avoiding strong food smells that might trigger nausea. Some patients find that ginger tea or ginger supplements can help reduce nausea, though you should check with your healthcare provider before adding any supplements to your regimen.

Vomiting is less common than nausea but can occur, particularly if you eat too much or eat too quickly while on GLP-1 medication. Because the medication slows gastric emptying, your stomach can't accommodate as much food as it could before treatment. If you overeat, you may experience uncomfortable fullness, nausea, or vomiting. Learning to recognise your new satiety signals and stopping eating when you feel comfortably full (rather than stuffed) can help prevent these symptoms.

Diarrhoea and constipation are both possible side effects, as GLP-1 medications affect gut motility. Some patients experience looser stools or diarrhoea, while others find they become constipated. Staying well-hydrated, eating adequate fibre from fruits, vegetables, and whole grains, and maintaining regular physical activity can help regulate bowel function. If constipation becomes problematic, your healthcare provider may recommend a fibre supplement or other strategies to help.

Decreased appetite is, of course, an intended effect of the medication rather than an unwanted side effect, but it's worth mentioning because the reduction in appetite can be quite dramatic for some patients. While this makes weight loss easier, it's important to ensure you're still eating enough to meet your nutritional needs. Some patients find they need to make a conscious effort to eat regular meals even when they don't feel particularly hungry, to ensure they're getting adequate protein, vitamins, and minerals.

Other potential side effects that occur less frequently include headache, fatigue or tiredness, dizziness, abdominal pain or discomfort, acid reflux or heartburn, injection site reactions (redness, itching, or discomfort at the injection site), and changes in taste. Most of these side effects are mild and temporary, resolving on their own as your body adjusts to the medication.

However, it is important to consult with a healthcare professional if you experience any persistent or severe side effects. They can provide guidance and adjust your treatment plan accordingly. There are also some more serious but rare side effects that require immediate medical attention. These include severe abdominal pain that doesn't go away, which could indicate pancreatitis, persistent vomiting that prevents you from keeping down fluids, signs of gallbladder problems such as pain in the upper right abdomen, yellowing of the skin or eyes, fever, or clay-coloured stools, signs of kidney problems such as changes in urination, swelling in the legs or feet, or unusual fatigue, severe allergic reactions such as difficulty breathing, swelling of the face or throat, or severe rash, and changes in vision or eye pain.

At Bodyline Clinic, we provide comprehensive support to help you manage any side effects that arise during your treatment. Your regular monitoring appointments give us the opportunity to assess how you're tolerating the medication, address any concerns, and make adjustments to your treatment plan if needed. We can provide practical advice on managing common side effects, adjust your dose if side effects are problematic, and ensure that any more serious symptoms are identified and addressed promptly. Our goal is to help you achieve successful weight loss while minimising discomfort and maintaining your overall health and wellbeing throughout the process.

GLP-1s and GLP's – GIP's for weight loss with Bodyline

At Bodyline Clinic, we offer GLP-1s and the combined GLP-1/GIP medications as part of our medically supervised weight loss programmes. Our experienced healthcare professionals will assess your eligibility and develop a personalised treatment plan tailored to your unique needs and goals. With our comprehensive approach, including medical weight loss treatments like GLP-1s / GLP-1s – GIP's injections or oral medication, dietary guidance, behaviour modification, and ongoing support, we can help you achieve sustainable weight loss and improve your overall health.

What sets Bodyline apart from other weight loss providers is our commitment to comprehensive, individualised care. We don't simply prescribe medication and send you on your way – we provide a complete support system designed to maximise your chances of long-term success. Our approach recognises that successful weight loss requires more than just medication; it requires addressing the behavioural, psychological, and lifestyle factors that contribute to obesity.

When you join a Bodyline weight loss programme, you become part of a supportive community of patients and healthcare professionals all working towards the same goal – helping you achieve and maintain a healthier weight. Our team includes experienced doctors, nurse prescribers, nutritionists, and support staff who are all dedicated to your success. We've helped over 100,000 patients across the UK achieve their weight loss goals over our 18 years of operation, and we bring this wealth of experience to every patient interaction.

Our medical weight loss programmes typically include an initial comprehensive assessment where we review your medical history, conduct necessary health checks including blood pressure and weight measurements, discuss your weight loss goals and previous attempts, and determine which treatment option is most appropriate for your circumstances. Based on this assessment, we'll develop a personalised treatment plan that may include GLP-1 or GLP-1/GIP injections, oral appetite suppressant medications like Phentermine or Diethylpropion, or a combination approach.

Throughout your treatment, you'll have regular monitoring appointments where we track your progress, assess how you're tolerating the medication, provide ongoing nutritional and lifestyle guidance, adjust your treatment plan as needed, and offer encouragement and support. These appointments can take place at one of our conveniently located clinics or via online consultation, depending on your preference and circumstances.

We also provide access to extensive educational resources through our online patient portal, including nutritional information and healthy eating guides, exercise and activity recommendations, strategies for managing emotional eating and food cravings, tips for maintaining weight loss long-term, and a supportive community where you can connect with other patients on similar journeys.

Remember, GLP-1s / GLP-1s – GIP's are a tool to assist you in your weight loss journey, but they should be used in conjunction with a supported and personalised weight loss programme and under the guidance of qualified healthcare professionals. By following a bespoke treatment plan and making sustainable lifestyle changes, you can achieve your weight loss goals and embark on a path to a slimmer and healthier you.

The medications provide powerful support by reducing hunger and making it easier to eat less, but long-term success requires developing new eating habits, increasing physical activity, addressing emotional and behavioural factors that contribute to overeating, and learning strategies to maintain your weight loss after treatment ends. This is why we emphasise the importance of lifestyle modification alongside medication – we want to help you not just lose weight, but keep it off for good.

Understanding how GLP-1 and dual GIP/GLP-1 medications work is a useful starting point when exploring medical weight management. The next step is understanding whether treatment could be appropriate for your own health needs, circumstances and goals.

Explore Your Options with Bodyline Clinic

At Bodyline Clinic, our clinical team can review your medical history, discuss your previous weight loss experiences and assess your suitability for treatment. You can ask questions about medication, potential side effects, ongoing support and what your programme would involve before making a decision.

If treatment is appropriate, regular consultations provide opportunities to discuss your progress, raise concerns and review your plan with your prescriber. Your care should reflect your individual needs and include a conversation about longer-term weight management.

To find out more about our medically supervised weight management programmes, contact Bodyline Clinic and speak to our team about your options.